You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Buy Disclosure
Lin Shao-lee · SEC Form 4 · Filed Jun 3, 2026
Buy
Calculated transaction value
$999.97K
Lin Shao-lee Chief Executive Officer
CUE
Cue Biopharma
CUE
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
CUE daily price context
Close on/before transaction
$24.07
Jun 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrants (Right to Buy) on Common Stock
- Quantity / price
- 90,906 shares @ $11
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001725092-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$999.97K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE Current | Buy | Jun 1, 2026 | $999.97K |
| Cue Biopharma, Inc. CUE | Buy | Jun 1, 2026 | Not reported |